FINWIRES · TerminalLIVE
FINWIRES

Barclays Initiates Forte Biosciences at Overweight With $74 Price Target

By

Forte Biosciences (FBRX) has an average rating of buy and mean price target of $66.60, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles